Antibody binding and ACE2 binding inhibition is significantly reduced for the Omicron variant compared to all other variants of concern
Daniel Junker, Matthias Becker, Teresa R. Wagner, Philipp D. Kaiser, Sandra Maier, Tanja M. Grimm, Johanna Griesbaum, Patrick Marsall, Jens Gruber, Bjoern Traenkle, Constanze Heinzel, Yudi T. Pinilla, Jana Held, View ORCID ProfileRolf Fendel, Andrea Kreidenweiss, Annika Nelde, Yacine Maringer, Sarah Schroeder, Juliane S. Walz, Karina Althaus, Gunalp Uzun, Marco Mikus, Tamam Bakchoul, Katja Schenke-Layland, Stefanie Bunk, Helene Haeberle, Siri Göpel, Michael Bitzer, Hanna Renk, Jonathan Remppis, Corinna Engel, Axel R. Franz, Manuela Harries, Barbora Kessel, Monika Strengert, Gerard Krause, Anne Zeck, Ulrich Rothbauer, View ORCID ProfileAlex Dulovic, View ORCID ProfileNicole Schneiderhan-Marra
doi: https://doi.org/10.1101/2021.12.30.21267519
Daniel Junker
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Matthias Becker
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Teresa R. Wagner
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
2Pharmaceutical Biotechnology, University of Tuebingen, Tuebingen, Germany
Philipp D. Kaiser
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Sandra Maier
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Tanja M. Grimm
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Johanna Griesbaum
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Patrick Marsall
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Jens Gruber
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Bjoern Traenkle
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Constanze Heinzel
3Institute of Tropical Medicine, University Hospital Tuebingen, Tuebingen, Germany
Yudi T. Pinilla
3Institute of Tropical Medicine, University Hospital Tuebingen, Tuebingen, Germany
Jana Held
3Institute of Tropical Medicine, University Hospital Tuebingen, Tuebingen, Germany
Rolf Fendel
3Institute of Tropical Medicine, University Hospital Tuebingen, Tuebingen, Germany
4German Center for Infection Research (DZIF), Partner Site Tuebingen, Tuebingen, Germany
5Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon
Andrea Kreidenweiss
3Institute of Tropical Medicine, University Hospital Tuebingen, Tuebingen, Germany
4German Center for Infection Research (DZIF), Partner Site Tuebingen, Tuebingen, Germany
5Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon
Annika Nelde
6Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany
7Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany
8Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
Yacine Maringer
6Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany
7Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany
8Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
Sarah Schroeder
7Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany
9Department of Otolaryngology, Head and Neck Surgery, University of Tuebingen, Tuebingen, Germany
Juliane S. Walz
6Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany
7Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany
8Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
10Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and Robert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany
Karina Althaus
11Center for Clinical Transfusion Medicine, Tuebingen, Germany
12Institute of Clinical and Experimental Transfusion Medicine, University Hospital Tuebingen, Tuebingen, Germany
Gunalp Uzun
11Center for Clinical Transfusion Medicine, Tuebingen, Germany
Marco Mikus
11Center for Clinical Transfusion Medicine, Tuebingen, Germany
Tamam Bakchoul
11Center for Clinical Transfusion Medicine, Tuebingen, Germany
12Institute of Clinical and Experimental Transfusion Medicine, University Hospital Tuebingen, Tuebingen, Germany
Katja Schenke-Layland
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
8Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
13Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, University of Tuebingen, Tuebingen, Germany
14Department of Medicine/Cardiology, University of California Los Angeles (UCLA), Los Angeles, USA
Stefanie Bunk
15Infectious Diseases, Department Internal Medicine I, University Hospital Tuebingen, Tuebingen, Germany
Helene Haeberle
16Department of Anaesthesiology and Intensive Care Medicine, University Hospital Tuebingen, Tuebingen, Germany
Siri Göpel
4German Center for Infection Research (DZIF), Partner Site Tuebingen, Tuebingen, Germany
15Infectious Diseases, Department Internal Medicine I, University Hospital Tuebingen, Tuebingen, Germany
Michael Bitzer
15Infectious Diseases, Department Internal Medicine I, University Hospital Tuebingen, Tuebingen, Germany
17Center for Personalized Medicine, University of Tuebingen, Tuebingen, Germany
Hanna Renk
18University Children’s Hospital, Tuebingen, Germany
Jonathan Remppis
18University Children’s Hospital, Tuebingen, Germany
Corinna Engel
18University Children’s Hospital, Tuebingen, Germany
19Center for Pediatric Clinical Studies, University Hospital Tuebingen, Tuebingen, Germany
Axel R. Franz
18University Children’s Hospital, Tuebingen, Germany
19Center for Pediatric Clinical Studies, University Hospital Tuebingen, Tuebingen, Germany
Manuela Harries
20Helmholtz Center for Infection Research, Braunschweig, Germany
Barbora Kessel
20Helmholtz Center for Infection Research, Braunschweig, Germany
Monika Strengert
20Helmholtz Center for Infection Research, Braunschweig, Germany
21TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture of Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany
Gerard Krause
20Helmholtz Center for Infection Research, Braunschweig, Germany
21TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture of Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany
Anne Zeck
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Ulrich Rothbauer
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
2Pharmaceutical Biotechnology, University of Tuebingen, Tuebingen, Germany
Alex Dulovic
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Nicole Schneiderhan-Marra
1NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted January 01, 2022.
Antibody binding and ACE2 binding inhibition is significantly reduced for the Omicron variant compared to all other variants of concern
Daniel Junker, Matthias Becker, Teresa R. Wagner, Philipp D. Kaiser, Sandra Maier, Tanja M. Grimm, Johanna Griesbaum, Patrick Marsall, Jens Gruber, Bjoern Traenkle, Constanze Heinzel, Yudi T. Pinilla, Jana Held, Rolf Fendel, Andrea Kreidenweiss, Annika Nelde, Yacine Maringer, Sarah Schroeder, Juliane S. Walz, Karina Althaus, Gunalp Uzun, Marco Mikus, Tamam Bakchoul, Katja Schenke-Layland, Stefanie Bunk, Helene Haeberle, Siri Göpel, Michael Bitzer, Hanna Renk, Jonathan Remppis, Corinna Engel, Axel R. Franz, Manuela Harries, Barbora Kessel, Monika Strengert, Gerard Krause, Anne Zeck, Ulrich Rothbauer, Alex Dulovic, Nicole Schneiderhan-Marra
medRxiv 2021.12.30.21267519; doi: https://doi.org/10.1101/2021.12.30.21267519
Antibody binding and ACE2 binding inhibition is significantly reduced for the Omicron variant compared to all other variants of concern
Daniel Junker, Matthias Becker, Teresa R. Wagner, Philipp D. Kaiser, Sandra Maier, Tanja M. Grimm, Johanna Griesbaum, Patrick Marsall, Jens Gruber, Bjoern Traenkle, Constanze Heinzel, Yudi T. Pinilla, Jana Held, Rolf Fendel, Andrea Kreidenweiss, Annika Nelde, Yacine Maringer, Sarah Schroeder, Juliane S. Walz, Karina Althaus, Gunalp Uzun, Marco Mikus, Tamam Bakchoul, Katja Schenke-Layland, Stefanie Bunk, Helene Haeberle, Siri Göpel, Michael Bitzer, Hanna Renk, Jonathan Remppis, Corinna Engel, Axel R. Franz, Manuela Harries, Barbora Kessel, Monika Strengert, Gerard Krause, Anne Zeck, Ulrich Rothbauer, Alex Dulovic, Nicole Schneiderhan-Marra
medRxiv 2021.12.30.21267519; doi: https://doi.org/10.1101/2021.12.30.21267519
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2970)
- Dermatology (253)
- Emergency Medicine (446)
- Epidemiology (12816)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4622)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2943)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (933)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4412)
- Nursing (238)
- Nutrition (652)
- Oncology (2296)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (282)
- Palliative Medicine (84)
- Pathology (503)
- Pediatrics (1200)
- Primary Care Research (503)
- Public and Global Health (7008)
- Radiology and Imaging (1545)
- Respiratory Medicine (921)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (185)